Print this page    •   Back to Web version of article

Medical News
FDA Approves Extended-Release Version of HIV Drug

April 6, 2011

The Food and Drug Administration has approved an extended-release form of the HIV drug nevirapine. Boehringer Ingelheim Pharmaceuticals' Viramune XR is a 400 mg tablet taken once daily; the earlier version required twice-daily dosing. "Viramune XR is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults," FDA said. Patients needing financial assistance to access the drug are asked to telephone 800-556-8317 or visit To read FDA's statement, visit

Back to other news for April 2011

Excerpted from:
Hartford Courant
04.04.2011; Rinker Buck

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.